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Background: Previous US-based studies have found that chronic kidney disease (CKD) disproportionately
affects those of more adverse social circumstances. Our aim was to show the association between socioeco-
nomic status (SES) and decreased kidney function in a European context and explore the role of obesity and
metabolic syndrome. We consider the potential confounding effect of lean muscle mass.
Study Design: Cross-sectional.
Setting & Participants: White participants in the follow-up of the Whitehall II cohort: UK-based European
population (age, 55-79 years; n  5,533), of whom 4,066 men (73%) and 1,467 women (27%) with complete
data were analyzed.
Predictors: Self-reported occupational grade/salary range.
Outcomes: Estimated glomerular filtration rate (GFR) using the CKD-EPI (CKD Epidemiology Collabora-
tion) equation.
Measurements: Body mass index (BMI), serum lipid levels, blood pressure, Tanita TBF-300 body composi-
tion analyzer, impedance-derived lean mass index (LMI).
Results: Participants in a lower compared with higher occupational grade were at increased odds of having
decreased GFR (age- and sex-adjusted OR, 1.31; 95% CI, 1.12-1.53; P  0.001). Socioeconomic disparity in
LMI was evident in women, but not men. After further adjustment for BMI and components of metabolic
syndrome, the odds of decreased GFR in whites with a lower compared with higher occupational grade was
attenuated by 23.3% (OR, 1.23; 95% CI, 1.06-1.45; P  0.008). Adjustment for LMI explained 15% of the
association between SES and estimated GFR.
Limitations: Cross-sectional design, missing data for subset of participants, no urinary data.
Conclusions: BMI and components of metabolic syndrome may explain up to a quarter of the association
between low SES and decreased GFR, suggesting potential modifiable factors.
Am J Kidney Dis. 58(3):389-397. © 2011 by the National Kidney Foundation, Inc. Published by Elsevier Inc. All
rights reserved.
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lipids; socioeconomic status.I t has been widely documented that those who areless affluent and/or of an ethnic minority back-
ground are over-represented in persons who develop
established kidney failure.1-8 Studies have examined
the association of socioeconomic status (SES) at the
individual and area levels with prevalence of earlier
stages of chronic kidney disease (CKD).9-18 Most of
these studies have been conducted in the United States
on biethnic populations using income and education
as measures of SES while simultaneously accounting
for the role of multiple behavioral and biological
factors, including smoking, alcohol, diabetes, and
hypertension.10-16
However, the pathways by which this socioeconomic
disparity in patients with CKD arises are not fully
understood. Metabolic manifestations of obesity (includ-
ing dyslipidemia, diabetes, and hypertension) have been
implicated in the increased cardiovascular risk and pro-
gressive renal insult in patients with CKD,19-23 with
evidence from SHARP(Study of Heart and Renal Protec-
tion) and meta-analyses of intervention with statins in
dyslipidemic individuals with CKD conferring renal and
cardiovascular benefit.24-27
Am J Kidney Dis. 2011;58(3):389-397Most observational studies have derived data using
serum creatinine–based estimated glomerular filtra-
tion rate (eGFR). Creatinine is a breakdown product
of muscle metabolism; serum creatinine levels are
influenced by the muscle mass of the study partici-
pant.28,29 Similarly, body mass index (BMI), a com-
monly used proxy of obesity, is influenced by not only
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Al-Qaoud et alfat, but also muscle mass of a person.19 Therefore,
analyses with outcome creatinine-derived eGFR and
exposure BMI as a proxy of obesity may be con-
founded by muscle mass.
Despite the increasing health burden, the role of
both obesity and metabolic syndrome in the SES-
CKD association has not been addressed in large
population-based cohorts. Analyses to date have not
allowed for confounding by socioeconomic differ-
ences in muscle mass.
Our aim was to show the prevalence of decreased
eGFR according to occupational grade in a large
UK-based European population (age, 55-79 years) by
conducting a cross-sectional analysis of data from the
Whitehall II cohort. We hypothesize that obesity and
dyslipidemia have a significant role in explaining the
increased risk of decreased eGFR in individuals with
a lower compared with higher occupational grade. We
include an analysis that adjusts for lean body mass,
examining its potential confounding effect in the
association between SES, potential risk factors, and
eGFR.
METHODS
StudyPopulation
Data for this cross-sectional analysis were drawn from the
Whitehall II cohort study of British civil servants, recruited from
men and women working in London government offices in 1985-
1988.30 The baseline sample consisted of 10,308 participants aged
35-55 years. Phase 9 of the study (2007-2009) was composed of
6,761 multiethnic participants who attended the medical screening
and completed the questionnaire, 5,725 of whom were white. Of
these eligible participants, a valid creatinine measurement was
obtained for 5,533 (96.6%) in addition to data for occupation
grade, obesity, and metabolic syndrome components, yielding a
sample of 4,066 white men (73%) and 1,467 women (27%) aged
55-79 years at phase 9. The University College London research
ethics committee had approved the study protocol, and participants
had given informed consent.
Kidney Function
We used the isotope-dilution mass spectrometry (IDMS)-
traceable CKD-EPI (CKD Epidemiology Collaboration) equa-
tion,31 consistent with the guidelines set by KDOQI (Kidney
Disease Outcomes Quality Initiative) and KDIGO (Kidney Dis-
ease: Improving Global Outcomes).32,33 For white men with a
creatinine level 0.9 mg/dL, the formula is 141  (serum creati-
nine/0.9)0.411  (0.993)age; for serum creatinine level 0.9
mg/dL, it is 141  (serum creatinine/0.9)1.209  (0.993)age. For
white women with a serum creatinine level 0.7 mg/dL, the
formula is 144  (serum creatinine/0.7)0.329  (0.993)age; for
serum creatinine level 0.7 mg/dL, it is 144  (serum creatinine/
0.7)1.209  (0.993)age. We analyzed eGFR (expressed in millili-
ters per minute per 1.73 m2) as a continuous variable and a
categorical binary variable denoting having or not having de-
creased GFR (defined here as eGFR60 mL/min/1.73 m2).
Socioeconomic Position
Occupational grade was self-reported by nonretired participants.
For those no longer working in the civil service, information for
390the most recent occupation grade was filled in from phase 8 back to
phase 1. Based on salary (salary ranges shown here are from 1992)
and work role, the civil service stratifies a hierarchy of employ-
ment grade. Of note, in this article, “higher grade” denotes higher
status grade and does not refer to the number assigned to the grade;
thus, grade 1 is higher (in occupational status) than grade 7. The
highest status grades are considered administrative and comprise
unified grades 1-6, with a salary range of £28,904-£87,620
($53,993-$163,674 at the 1992 conversion factor of 1.868; equiva-
lent to Whitehall II Study grade 1) and unified grade 7, a lower
status administrative grade with salary range of £25,330-£36,019
($47,316-$67,283; Whitehall II grade 2). Executive grades include
Senior Executive Officer, salary range of £18,082-£25,554
($33,777-$47,735; Whitehall II grade 3); Higher Executive Offi-
cer, salary range of £14,456-£20,850 ($27,004-$38,948; Whitehall
II grade 4); and Executive Officer, salary range of £8,517-£16,668
($15,910-$31,136; Whitehall II grade 5). Clerical and support staff
have a salary range of £7,387-£11,917 ($13,799-$22,261; White-
hall II grade 6).30 For the purpose of aiding interpretation and
analysis, occupational grade was analyzed in 3 levels of decreasing
status: high status, administrative (Whitehall II grades 1-2); me-
dium status, executive (Whitehall II grades 3-5); and low status,
clerical and support staff (Whitehall II grade 6).
Obesity andComponents ofMetabolic Syndrome
BMI (weight in kilograms divided by height in meters squared)
was analyzed in sex-specific quartiles. The Adult Treatment Panel
III (ATP III)34 defines components of metabolic syndrome as
central obesity (waist circumference102 cm in men and88 cm
in women), dyslipidemia (triglyceride level 150 mg/dL), high-
density lipoprotein (HDL) cholesterol level (40 mg/dL in men
and 50 mg/dL in women), blood pressure (130/85 mm Hg),
and fasting plasma glucose level (110 mg/dL). The association
of each of these components was assessed independently and
simultaneously. Blood pressure was treated as 2 components,
systolic and diastolic, for analytic purposes. These measures were
used as sex-specific quartiles for stratified analysis and cohort-
specific quartiles for pooled analysis.
LeanMass Index andFat- FreeMass
Height was measured in a standard fashion with the head in the
Frankfurt plane. The Tanita TBF-300 body composition analyzer
(Tanita, www.tanita.com/en/) is a leg-to-leg pressure contact sys-
tem consisting of 2 subdivided stainless steel footpad electrodes
that are mounted on a platform scale, generating impedance of
lower extremities.35 Fat-free mass (FFM) was calculated directly
by the Tanita instrument. A proxy of lean mass index (LMI) was
calculated from raw impedance output by the Tanita instrument as
described next. The formula used to calculate this proxy of LMI is
based on the observation that impedance is a function of total-body
water (TBW), such that TBW is proportional to the square of
height divided by impedance (R), in other words, TBWHeight2/R,
which, after adjustment for hydration of lean tissue (HLT), calcu-
lates lean mass (LM). Thus, given that LM  TBW/HLT, the
relationship can be simplified to LMI is proportional to (Height2/
R)/HLT/Height2, Height2 cancels out; thus, LMI  1/(R  HLT).
Our population is of homogenous age, which means that HLT in
this formula is a sex-specific constant. When analyses of a popula-
tion study are conducted adjusted for sex or within each sex,
differences in LMI between study participants are driven by the
bioimpedance analysis index (BAI) 1/R, in other words, relative
differences in BAI capture relative LMI differences between study
participants. BAI as a proxy measure of LMI for population-based
research has been validated and used for previous research studies
in this area. Full details of the BAI are published elsewhere by
Wells et al.36
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Obesity, SES, and GFR in Whitehall IIStatistical Analysis
Descriptive statistics for participants, including crude frequency
proportions with 2 tests for trend by occupational grade and crude
mean values with age-adjusted tests for trend (using linear regres-
sion), are presented stratified by occupational grade and sex. Using
age-adjusted linear and logistic regression models, differences in
BMI and metabolic syndrome components according to occupa-
tion grade and the odds of decreased GFR according to all factors
under study were computed stratified by sex as a means of testing
the pattern, strength, and magnitude of associations with the main
outcome and exposures. Pearson correlation test between LMI,
fat-free mass, and waist circumference was calculated. Optimal
terms for age adjustment were tested using log-likelihood ratio
test, with no evidence of nonlinearity of the association (likelihood
ratio test, P  0.9 for men and P  0.7 for women [quadratic
model] and P  0.9 for men and P  0.9 for women [categorical
model]).
Multivariable logistic regression models were computed to
determine the presence and magnitude of the association between
low SES and decreased GFR using occupational grade. Log-
likelihood ratio tests were used to test for a sex–occupational grade
interaction. The potential significant mediating role of obesity and
metabolic syndrome components was explored by adding each
factor independently to the multivariable logistic model containing
age, sex, occupational grade, and decreased GFR and calculating
the percentage of attenuation by each factor, independently and
simultaneously, by subtracting the log odds of decreased GFR after
adding factors to the model from the log odds of decreased GFR of
the basic model, then dividing by the log odds of decreased GFR of
the basic model. In a subgroup of 4,838 participants with imped-
ance measurements (3,627 men and 1,211 women), the confound-
ing role of muscle mass in the associations between decreased
GFR and all factors under study was addressed by adjusting for the
proxy of LMI (ie, bioimpedance analysis index).
Sensitivity analyses were carried out using eGFR calculated
using the IDMS-traceable MDRD (Modification of Diet in Renal
Disease) Study equation37 and also using linear regression analy-
ses with comparable results that were consistent with those shown
in this report. Adjustment for prevalent diabetes and non-HDL
cholesterol level also was conducted. Statistical analyses were
conducted using Stata, version 10 (StataCorp LP, www.stata.
com).38
RESULTS
Participant Characteristics
Of 5,533 white European participants (4,066 men
and 1,467 women), men had a mean age of 65.5 years,
and women, 65.9 years. Most men were in the top
administrative grade (58.6%) and nearly half the
women were in the middle executive grade (49.7%).
Age-adjusted mean eGFRs were similar in men and
women (79.7 and 79.4 mL/min/1.73 m2). Prevalences
of eGFR 60 mL/min/1.73 m2 in the cohort were
7.8% for men and 11.0% for women (Fig 1). The
highest percentage of obesity was observed in men
and women of clerical/office support compared with
higher occupational grades (P  0.001; Table 1).
However, men of all occupational grades had a less
favorable level of each component of metabolic syn-
drome compared with women of all occupational
grades (Table 1). Lower occupational grade was asso-
Am J Kidney Dis. 2011;58(3):389-397ciated with a higher prevalence of decreased GFR
compared with a higher occupational grade in both
sexes, and women of clerical/office support grade had
a lower percentage of eGFR category 90 mL/min/
1.73 m2 compared to men of clerical/office support
grade (Fig 1; Table 2).
AssociationofAge,Obesity, andMetabolic Syndrome
ComponentsWithDecreasedGFR
A 1-year increase in age conferred a 15%-16%
increased odds of decreased GFR. Using sex-specific
quartiles of variables (Table 3), obese men and women
compared with underweight/normal-weight men and
women had 96% and 101% increased odds of de-
creased GFR after adjustment for age, respectively.
Of metabolic syndrome components, increasing tri-
glyceride levels are linked most clearly to GFR, with
individuals in the highest compared with the lowest
quartile having 177% and 155% increased odds of
decreased GFR for men and women, respectively.
Having diabetes was associated with increased odds
of decreased GFR in men, but not women. Associa-
tions of factors with kidney function as a continuous
measure are listed in Table S1 (available as online
supplementary material).
Fat-FreeMass andLMI
In participants with body impedance measures,
socioeconomic disparity in raw impedance and differ-
ences in LMI was evident in women, but not men
(P  0.01 and P  0.3 for impedance; P  0.01 and
P  0.2 for LMI, respectively). In both men and
women, there was an association between decreased
eGFR and increasing quartiles of LMI (P 0.001 for
both; data not shown). After adjustment for LMI, the
negative association of being in the highest versus
Figure 1. Percentage of participants with decreased glomer-
ular filtration rate (GFR) by occupational grade and sex. P value
for trend calculated using a regression model adjusted for age.
Decreased GFR defined as GFR estimate 60 mL/min/1.73 m2
using the isotope-dilution mass spectrometry–traceable CKD-
EPI (Chronic Kidney Disease Epidemiology Collaboration) equa-
tion. Total percentage of cases was 7.8% in men and 11.0% in
women.lowest quartile of triglyceride levels with GFR re-
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Table 1. Characteristics of Study Participants by Socioeconomic Status (Occupational Grade)
Characteristic
Men Women
Total
(n  4,066)
Clerical/Office
Support Executive Administrative
P for
Trend
Total
(n  1,467)
Clerical/Office
Support Executive Administrative
P for
Trend
Total 4,066 (73) 141 (3.5) 1,539 (37.9) 2,386 (58.6) 1,467 (27) 338 (23.0) 729 (49.7) 400 (27.3)
Age (y) 65.5  5.8 65.5  5.9 65.1  5.8 65.8 5.8 0.001 65.9  6.1 68.3  6.0 65.7  6.0 64.0 5.6 0.001
Age group 0.007 0.001
55-59 y 822 (20.2) 31 (21.9) 354 (23.0) 437 (18.3) 301 (20.5) 34 (10.0) 146 (20.0) 121 (30.3)
60-64 y 1,339 (32.9) 43 (30.5) 522 (33.9) 774 (32.4) 427 (29.1) 81 (23.9) 218 (29.9) 128 (32.0)
65-69 y 833 (20.5) 27 (19.2) 289 (18.8) 517 (21.7) 299 (20.4) 67 (19.8) 151 (20.7) 81 (20.2)
70-74 y 752 (18.5) 31 (21.9) 267 (17.3) 454 (19.0) 317 (21.6) 106 (31.3) 160 (22.0) 51 (12.8)
75 y 320 (7.9) 9 (6.4) 107 (6.9) 204 (8.6) 123 (8.4) 50 (14.8) 54 (7.4) 19 (4.7)
BMI (kg/m2) 26.5  3.9 27.1  4.7 26.8  4.0 26.4 3.8 0.001a 27.1  5.5 27.9  5.4 27.2  5.5 25.9 5.4 0.001a
BMI category 0.001 0.001
Underweight/normal
(18.5-25 kg/m2)
1,482 (36.5) 50 (35.5) 518 (33.7) 914 (38.3) 604 (41.2) 111 (32.8) 281 (38.5) 212 (53.0)
Overweight (25-30 kg/m2) 1,920 (47.3) 55 (39.0) 752 (48.8) 1,113 (46.7) 474 (32.3) 116 (34.4) 257 (35.3) 101 (25.2)
Obese (30 kg/m2) 664 (16.2) 36 (25.5) 269 (17.5) 359 (15.0) 389 (26.5) 111 (32.8) 191 (26.2) 87 (21.8)
Waist circumference (cm) 95.3  10.8 96.5  13.6 95.9  11.1 94.9  10.5 0.001a 85.2  12.8 87.4  12.8 85.0  12.4 83.0  13.2 0.001a
Systolic BP (mm Hg) 126.0  15.4 121.8  14.7 126.2  15.4 126.2 15.5 0.002a 123.2  17.4 124.9  16.4 124.4  18.3 119.6 16.2 0.06a
Diastolic BP (mm Hg) 71.8  10.1 89.2  9.6 72.0  10.1 71.7  10.0 0.2a 69.4  10.2 69.8  10.2 69.7  10.2 68.8  10.2 0.2a
HDL cholesterol (mg/dL) 58.3  15.4 55.4  15.4 57.4  15.2 59.0  15.6 0.001a 72.3  18.6 69.1  17.2 71.3  17.9 76.9  20.4 0.001a
Triglycerides (mg/dL) 114.4  70.3 123.1  30.5 118.0  28.8 111.6 29.0 0.006a 103.7  54.8 111.7  27.2 105.6  26.3 93.6  24.7 0.001a
Fasting glucose (mg/dL) 96.9  22.0 96.1  22.5 98.2  25.1 96.2  19.7 0.03a 93.9  22.7 95.3  27.2 94.1  22.6 92.5  18.5 0.3a
Diabetes prevalence 0.002 0.01
No 3,652 (89.8) 120 (85.1) 1,358 (88.2) 2,174 (91.1) 1,302 (88.8) 292 (86.4) 639 (87.6) 371 (92.8)
Yes 414 (10.2) 21 (14.9) 181 (11.8) 212 (8.9) 165 (11.2) 46 (13.6) 90 (12.4) 29 (7.2)
Note: Categorical values shown as number (percentage); continuous variables, as mean standard deviation by occupational grade in men and women. For purposes of the analysis in this
article, clerical and office support is considered low occupational grade; executive, medium grade; and administrative, high grade. Conversion factors for units: HDL cholesterol in mg/dL to
mmol/L,0.02586; triglycerides in mg/dL to mmol/L,0.01129; glucose in mg/dL to mmol/L,0.05551.
Abbreviations: BMI, body mass index; BP, blood pressure; HDL, high density lipoprotein.
aAge-adjusted P values for trend.
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Obesity, SES, and GFR in Whitehall IImains in both sexes, and the protective association of
HDL cholesterol level remains in men only (Tables S2
and S3). Additional LMI adjustment attenuates asso-
ciations of the remaining components of metabolic
syndrome to insignificance in men and all compo-
nents except BMI in women (Table S3). Adjustment
for fat-free mass generated by the Tanita instrument as
a measure of muscle mass showed similar results
(data not shown). LMI and fat-free mass correlated
highly with waist circumference in men and women
(Pearson coefficient of 0.4 in men and 0.5 in women
for LMI and 0.6 for men and 0.7 for women for
fat-free mass).
OccupationalGradient in CKDand theRole ofObesity
andMetabolic Syndrome
Participants with a lower occupational grade were
at 31% increased odds of decreased GFR (age- and
sex-adjusted odds ratio [OR], 1.31; 95% confidence
interval [CI], 1.12-1.53; P  0.001) in comparison to
those in a higher occupational grade (Table 4). There
was no evidence for a difference in the occupational
grade effect on GFR between men and women (Table
4; P  0.3 for likelihood ratio test). Adjusting for
BMI attenuated the association by 14.4%, and adjust-
ment for all components of metabolic syndrome attenu-
ated the association by 20%. Adjustment for serum
HDL cholesterol and triglyceride (dyslipidemia) lev-
els decreased the excess odds of having decreased
GFR in individuals in lower grades by 17.6%, whereas
adjustment for BMI and dyslipidemia combined de-
creased the risk by 23.3%. Adjustment for non-HDL
cholesterol level and prevalent diabetes (data not
shown) did not attenuate the odds appreciably. Adjust-
ment for age, sex, BMI, and all components of meta-
bolic syndrome did not result in greater attenuation.
The occupation grade effect remained significant in
Table 2. Distribution of Men and Women Across eGFR
eGFR
Categorya
Men
Total
(n  4,066)
Clerical/Office
Support Executive Administrative
90 1,035 (25.5) 44 (31.2) 406 (26.4) 585 (24.5)
60-89 2,713 (66.7) 83 (58.9) 1,004 (65.2) 1,626 (68.2)
45-59 262 (6.4) 12 (8.5) 103 (6.6) 147 (6.2)
30-44 47 (1.2) 2 (1.4) 21 (1.4) 24 (1.0)
30 9 (0.2) 0 (0) 5 (0.3) 4 (0.1)
Note: Values shown are number (percentage). For purposes of
occupational grade; executive, medium grade; and administrative
Abbreviation: eGFR, estimated glomerular filtration rate.
aeGFR calculated using the CKD-EPI (Chronic Kidney Disease
bUnadjusted P value for trend.the maximally adjusted model.
Am J Kidney Dis. 2011;58(3):389-397In the sample with impedance measurements, par-
ticipants in lower occupation grades were at 13%
increased odds of decreased GFR, and analysis strati-
fied by sex shows that the effect was significant in
women only (Table S2), with women in lower occupa-
tional grades having a 55% increased odds of de-
creased GFR compared with those in higher occupa-
tion grades (P  0.02; P  0.09 for likelihood ratio
test for sex–SES grade interaction). Adjustment for
LMI explained 15% of the SES-GFR association in
the sample (adjusted OR, 1.11; 95% CI, 0.90-1.37)
and 6% of the association in women (adjusted OR,
1.51; 95% CI, 1.03-2.23).
DISCUSSION
We show in a UK white population of 5,533 men
and women that individuals of lower SES more often
have early kidney function decrease compared with
those of higher status measured using civil service
occupational grade. Our study implicates obesity and
metabolic syndrome in the association between SES
and decreased GFR, whereby each independently
explains about one-sixth and in combination account
for almost a quarter of the increased odds of having
decreased GFR seen in individuals with lower status.
Our results are in line with previous studies that
have examined the role of individual income and
education in CKD.10,11,13,14 In contrast to our find-
ings, Peralta et al16 found that occupation (based on
white- and blue-collar criteria) was not associated
with kidney function in either African American or
white participants from the Cardiovascular Health
Study. Using a life course approach, Shoham et al15
showed that ORs for CKD in working class versus
non–working class individuals at age 30 years were
1.4 (95% CI, 1.0-1.9) in whites and 1.8 (95% CI,
1.1-3.0) in blacks. A case-control study in Sweden17
gories by Socioeconomic Status (Occupational Grade)
Women
r
d
Total
(n  1,467)
Clerical/Office
Support Executive Administrative
P for
Trend
b 0.001b
419 (28.6) 72 (21.3) 210 (28.8) 137 (34.3)
887 (60.5) 209 (61.8) 435 (59.7) 243 (60.8)
127 (8.7) 47 (13.9) 62 (8.5) 18 (4.5)
30 (2.0) 9 (2.7) 20 (2.7) 1 (0.3)
4 (0.3) 1 (0.3) 2 (0.3) 1 (0.2)
nalysis in this article, clerical and office support is considered low
h grade.
emiology Collaboration) equation and given in mL/min/1.73 m2.Cate
P fo
Tren
0.3
the a
, hig
Epidinvolving 1,894 participants aged 18-74 years used
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Al-Qaoud et alhighest occupation grade of spouses and parents as a
measure of household SES and found that women in
families with only unskilled workers had a 2-fold
increase in odds of CKD in comparison to women in
families of professionals. The corresponding excess
odds of preuremic CKD in men was 60% in the lowest
versus highest household SES. These findings show
that associations between grade/social class and CKD
are present for both men and women. None of the
studies mentioned to date explored the role of dyslipi-
Table 3. Association of Decreased GFR W
Factor
(n
OR (95% CI)
Age (/1-y increase) 1.16 (1.14-1.1
Occupational grade (/grade decrease) 1.26 (1.03-1.5
BMIa
Overweight 1.66 (1.26-2.1
Obese 1.96 (1.38-2.8
Waist circumferenceb
Q2 1.52 (1.04-2.2
Q3 1.82 (1.27-2.6
Q4 2.02 (1.41-2.9
Systolic BPb
Q2 0.64 (0.45-0.9
Q3 0.71 (0.50-1.0
Q4 1.18 (0.87-1.6
Diastolic BPb
Q2 0.80 (0.57-1.1
Q3 0.94 (0.67-1.3
Q4 1.42 (1.03-1.9
HDL cholesterolb
Q2 0.68 (0.50-0.9
Q3 0.66 (0.46-0.9
Q4 0.50 (0.36-0.7
Triglyceridesb
Q2 1.57 (1.10-2.2
Q3 2.14 (1.53-3.0
Q4 2.77 (1.93-3.9
Fasting glucoseb
Q2 0.86 (0.61-1.2
Q3 0.92 (0.65-1.2
Q4 1.14 (0.83-1.5
Diabetes prevalence (yes vs no) 1.54 (1.11-2.1
Note: ORs shown are age adjusted by sex for the associatio
IDMS-traceable CKD-EPI equation) with BMI and components
model). Conversion factors for units: HDL cholesterol in mg/dL
glucose in mg/dL to mmol/L,0.05551.
Abbreviations: BMI, body mass index; BP, blood pressure; CI,
Collaboration; eGFR, estimated GFR; GFR, glomerular filtratio
spectrometry; OR, odds ratio; Q, quartile.
aReference group is participants in underweight/normal-weigh
bReference group is lowest quartile (Q1) for each set of sex-spdemia on the occupational gradient of CKD, but most
394studies addressed the role of BMI, hypertension, and
diabetes. In addition, a study that has attempted to
explore the role of lipid levels and other factors
associated with metabolic syndrome carried out by
Kurella et al20 showed that in 10,096 nondiabetic
individuals with normal baseline kidney function from
the ARIC (Atherosclerosis Risk in Communities) trial,
participants with metabolic syndrome (ATP III guide-
lines) had an adjusted 43% increased odds of develop-
ing CKD after a 9-year follow-up (OR for eGFR60
MI and Metabolic Syndrome Components
66)
Women
(n  1,467)
P OR (95%CI) P
0.001 1.15 (1.12-1.18) 0.001
0.03 1.43 (1.11-1.83) 0.005
0.001 1.56 (1.02-2.40) 0.03
0.001 2.01 (1.31-3.09) 0.001
0.02 1.19 (0.70-2.03) 0.5
0.001 1.37 (0.81-2.31) 0.2
0.001 1.68 (1.01-2.80) 0.04
0.02 1.00 (0.57-1.75) 0.9
0.06 1.30 (0.77-2.19) 0.3
0.3 1.42 (0.85-2.39) 0.2
0.2 1.14 (0.69-1.90) 0.6
0.7 1.00 (0.59-1.69) 0.9
0.03 1.93 (1.21-3.09) 0.005
0.01 0.63 (0.40-1.00) 0.05
0.03 0.65 (0.41-1.03) 0.06
0.001 0.65 (0.39-1.07) 0.08
0.01 1.35 (0.75-2.43) 0.3
0.001 2.53 (1.56-4.11) 0.001
0.001 2.55 (1.57-4.13) 0.001
0.4 0.73 (0.44-1.20) 0.2
0.6 1.09 (0.68-1.76) 0.7
0.4 1.46 (0.93-2.29) 0.09
0.009 1.02 (0.62-1.66) 0.9
decreased GFR (eGFR 60 mL/min/1.73 m2 according to the
tabolic syndrome (each row refers to a separate age-adjusted
mol/L, 0.02586; triglycerides in mg/dL to mmol/L, 0.01129;
dence interval; CKD-EPI, Chronic Kidney Disease Epidemiology
te; HDL, high-density lipoprotein; IDMS, isotope-dilution mass
gory.
quartiles of factors.ith B
Men
 4,0
8)
4)
9)
0)
1)
2)
0)
1)
1)
1)
4)
0)
5)
2)
5)
1)
5)
0)
7)
2)
9)
7)
4)
n of
of me
to m
confi
n ra
t catemL/min/1.73 m2 using the MDRD Study equation,
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Obesity, SES, and GFR in Whitehall II1.43; 95% CI, 1.18-1.73). For individual metabolic
syndrome traits, except for impaired fasting glucose
level, each component of metabolic syndrome was
associated with a significantly increased risk of CKD,
a finding similar to our study’s results. Individuals
with increased triglyceride and low HDL cholesterol
levels were at 34% and 27% increased odds of devel-
oping CKD. Even after adjustment for the subsequent
development of diabetes and hypertension during the
9-year follow-up, the OR of incident CKD remained
significant, emphasizing that individuals with meta-
bolic syndrome have an independent increased risk of
incident CKD. Diabetes accounted for 3% of the
SES-GFR association in our sample. However, this
should be interpreted with caution because our ap-
proach was cross-sectional and the well-established
longitudinal association between diabetes and CKD
would have been examined better using data for actual
date of diagnosis. The obscured effect of systolic
blood pressure on kidney function also may have been
underestimated because of measurement error.
Our adjustment for LMI as a proxy measure of
muscle mass shows how sex differences in muscle
mass influence creatinine-based equations. Adjust-
ment for LMI explained 15% of the SES-GFR associa-
tion in the sample as a whole, suggesting that LMI is a
positive confounder of the SES-GFR association, as
hypothesized. Despite the absence of data for direct
measurement of GFR in our study for comparison,
Table 4. Association of Decreased GFR W
Adjustment Factor
Base modelb  Age, sex
Obesity model  BMI
Components of MS model Waist circumference
 Systolic BP
 Diastolic BP
 HDL cholesterol
 Triglycerides
 Fasting glucose
 All MS components
Dyslipidemia model  HDL cholesterol, triglycerides
Obesity & dyslipidemia
model
 BMI, HDL cholesterol,
triglycerides
Obesity & MS All factors combined
Note: ORs shown are of decreased GFR (eGFR 60 mL/min/
versus higher occupational grades adjusted for age, sex, an
components (each model includes basic model in addition to spe
Abbreviations: BMI, body mass index; BP, blood pressure; CI,
Collaboration; eGFR, estimated GFR; GFR, glomerular filtratio
spectrometry; LRT, likelihood ratio test; MS, metabolic syndrome
aLRT P value indicates the significance of adding variables to t
bTest for sex difference in grade effect in CKD, P 0.3 (LRT).these results point to the importance of adjustment for
Am J Kidney Dis. 2011;58(3):389-397lean body mass or muscle mass in creatinine-based
eGFR.
Strengths of this study include use of a large cohort,
use of occupation grade as an individual’s measure of
SES in a stratified sample of working environment
within the UK civil service independent of racial and
ethnic effects, adjustments for proxies of lean body
mass, and use of the recently devised CKD-EPI equa-
tion to estimate GFR.31 Our study is novel in terms of
addressing the role of obesity and all factors of
metabolic syndrome simultaneously and in our explo-
ration of the confounding role of muscle mass in the
associations between SES, risk factors, and eGFR.
However, our study does not come without limita-
tions, and caution has to be taken when interpreting
our findings. Limitations inherent in cross-sectional
studies operate here. Of major importance is our
inability to ascertain firm causality between SES and
decreased GFR and the potential mediating role of
obesity and metabolic syndrome. Another main limita-
tion is the absence of urinary markers (proteinuria/
albuminuria). Relating to our measure of SES, occupa-
tional grade was based on salary and work role,
pointing to the limitation that salary may not reflect
SES, depending on nonwage income and number of
wage earners in the family unit. Although these fac-
tors potentially are important for women in our study,
we observe clearer SES differences in decreased GFR
prevalence in women than men. Additionally, there is
ower Versus Higher Occupational Grade
(95% CI) P
%
Attenuation
P for Sex
Interaction LRT Pa
(1.12-1.53) 0.001 — 0.3 Age, 0.001;
sex, 0.2
(1.08-1.47) 0.004 14.4 0.4 0.001
(1.09-1.49) 0.002 8.6 0.3 0.001
(1.13-1.54) 0.001 0 0.3 0.07
(1.13-1.54) 0.001 0 0.3 0.003
(1.09-1.49) 0.003 11.1 0.4 0.001
(1.07-1.47) 0.005 17.6 0.4 0.001
(1.12-1.53) 0.001 0 0.2 0.07
(1.07-1.46) 0.001 20 0.4 0.001
(1.09-1.49) 0.006 17.6 0.4 0.001
(1.05-1.45) 0.009 23.3 0.5 0.001
(1.06-1.45) 0.008 23.3 0.5 0.001
m2 according to the IDMS-traceable CKD-EPI equation) in lower
ther sequential adjustments for obesity (using BMI) and MS
factors). N 5,533.
dence interval; CKD-EPI, Chronic Kidney Disease Epidemiology
te; HDL, high-density lipoprotein; IDMS, isotope-dilution mass
, odds ratio.
odel.ith L
OR
1.31
1.26
1.28
1.31
1.32
1.27
1.25
1.31
1.24
1.25
1.23
1.23
1.73
d fur
cified
confi
n ra
; OR
he moverlap in income at the margins of the salary ranges
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Al-Qaoud et alfor each grade. However, income is only one of
several defining features of SES, and occupational
grade in the civil service is a strong predictor of health
outcomes, health behaviors, and aging outcomes.39-41
Regarding demographic features of our sample from
the Whitehall II cohort, the small number of men in
the lowest occupational grade may have limited the
power of the analysis to detect differences, and Fig 1
suggests a shallower gradient in men than women
between the middle and top occupational grades.
Apart from the usual problem of not having gold-
standard measurements of GFR (outcome measure-
ment error), there might be additional measurement
bias as a result of our use of the Tanita instrument to
obtain BMI and impedance to estimate LMI in our
adjusted analysis. However, our use of LMI over
fat-free mass output from the Tanita instrument previ-
ously has been shown to be a more accurate method to
quantify total-body water.36 Losses to follow-up are
inevitable in longitudinal cohorts, and our participants
were gathered from a sample representing 67% of the
original cohort size (10,308). Our analyses of a sample
of whites might be regarded as a limitation given the
clear racial disparity in end-stage renal disease. How-
ever, our design (restricted to whites) ensured that
there was no confounding by ethnic minority status.
Obesity and dyslipidemia are potentially plausible
factors that may explain the socioeconomic disparity
in early kidney function decline.
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SUPPLEMENTARY MATERIALS
Table S1: Age-adjusted association of BMI and components of
metabolic syndrome with eGFR as a continuous measure, stratified
by sex.
Table S2: Age-adjusted association of decreased GFR with BMI
and components of the metabolic syndrome, by sex, in participants
with impedance measurements.
396Table S3: Age- and lean mass index–adjusted association of
decreased GFR with BMI and components of the metabolic
syndrome, by sex, in participants with impedance measurements.
Note: The supplementary material accompanying this article
(doi:10.1053/j.ajkd.2011.04.017) is available at www.ajkd.org.
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